ALLOSOURCE LAUNCHES ALLOMEND DUO ACELLULAR DERMAL MATRIX, A NATURAL SOLUTION FOR NON-DIRECTIONAL IMPLANTATION IN SOFT TISSUE RECONSTRUCTION

CENTENNIAL, Colo., May 25, 2023 /PRNewswire/ — AlloSource®, one of the largest nonprofit allograft providers in the U.S. creating innovative cellular and tissue products to help surgeons heal their patients, today announced the launch of AlloMend® Duo Acellular Dermal Matrix (ADM), a natural solution for soft tissue reconstruction. NEW AlloMend Duo Acellular Dermal Matrix, a … Read more